SSG Advises BIOLASE, Inc. in the Sale of Substantially all Assets to MegaGen Implant Co., Ltd.
SSG Capital Advisors, LLC (“SSG”) served as the investment banker to BIOLASE, Inc. (“BIOLASE” or the “Company”) in the sale of substantially all assets to MegaGen Implant Co., Ltd. (“MegaGen”). The sale was effectuated through a Chapter 11 Section….
READ MORESSG Advises Ovalnnovations in the Sale to Veos USA Inc.
SSG Capital Advisors, LLC (“SSG”) served as the investment banker to Anada Inc., OvaInnovations, LLC, and Crimson Holdings, LLC (collectively, “OvaInnovations” or the “Company”) in the sale of substantially all its assets to Veos USA Inc. (“Veos”). The sale….
READ MORESSG Advises Trugman-Nash, LLC in its Sale to Arthur Schuman, Inc.
SSG Capital Advisors, LLC (“SSG”) served as the investment banker to Trugman-Nash, LLC (“Trugman-Nash” or the “Company”), a subsidiary of Allied Dairy Products, Inc., in the sale of 100% of its equity ownership interests to Arthur Schuman, Inc. d/b/a….
READ MORESSG Advises Harrison Senior Living in the Sale of its Skilled Nursing Facilities to an Affiliate of Emerald Group
SSG Capital Advisors, LLC (“SSG”) served as the investment banker to Harrison Enterprises Limited Partnership and Affiliates (“Harrison Senior Living” or the “Company”) in the sale of its skilled nursing facilities to an affiliate of Emerald HCG LLC (“Emerald….
READ MORESSG Advises Eiger BioPharmaceuticals Inc. in the Sale of Lonafarnib and Lambda Program Assets to Eiger InnoTherapeutics, Inc.
SSG Capital Advisors, LLC (“SSG”) served as the investment banker to Eiger BioPharmaceuticals, Inc. (“Eiger” or the “Company”) in the sale of Lonafarnib and Lambda, and associated clinical assets to Eiger InnoTherapeutics, Inc. The sale was effectuated through a….
READ MORE